CTRI/2021/08/035398
Not yet recruiting
未知
Clinico-hematological profile of chronic myeloid leukemia in a tertiary care hospital
DRREETIKA RAMANATHA0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: C921- Chronic myeloid leukemia, BCR/ABL-positive
- Sponsor
- DRREETIKA RAMANATHA
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Newly diagnosed cases of CML. 2\.Follow up cases of CML
Exclusion Criteria
- •1\.Patients who are unwilling to give written informed consent.
- •2\.Patients lost to follow up.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The Observational Study of Chronic Myeloid Leukemia Patients in Chronic Phase with Resistance or Intolerance to Preceding TKI in JapaJPRN-UMIN000003582The Japanese Society of Hematology110
Unknown
Not Applicable
The Hong Kong CML RegistryChronic Myeloid LeukemiaNCT03625583The University of Hong Kong200
Completed
Not Applicable
The Observational Study of De Novo Chronic Myeloid Leukemia Patients in Chronic Phase in JapaChronic Myeloid LeukemiaJPRN-UMIN000003581The Japanese Society of Hematology500
Completed
Not Applicable
CML IV - Chronic phase chronic myeloid leukaemia/CML 2000eukaemiaCancerChronic myeloid leukaemiaISRCTN61147621Medical Research Council (MRC) (UK)800
Active, not recruiting
Phase 1
Management of Transformed Chronic myeloid leukaemia: Ponatinib and Intensive chemotherapy: a dose-finding studyEUCTR2012-005629-65-GBniversity of Birmingham15